Is birth a critical period in the pathogenesis of autism spectrum disorders?
Crossref DOI link: https://doi.org/10.1038/nrn3956
Published Online: 2015-07-08
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ben-Ari, Yehezkel
Text and Data Mining valid from 2015-07-08
Article History
First Online: 8 July 2015
Competing interests
: The author is founder and CEO of Neurochlore, a company devoted to study autism and develop a treatment based on the regulation of intracellular chloride.